MCMINN RACHEL (Chief Executive Officer) purchased 3.8% of their position (47.50K shares) of NEUROGENE INC. on the open market
Open‑market purchase worth $969.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/25/2024ACC: 0001404644-24-000112
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+47.50K
Net shares
Net buyer
$969.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
47.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+47.50K
Price / share
$20.40
Trade value
$969K
% of position
3.8%
11/22/2024
1.25M→1.30M
Total
Net shares
+47.50K
Net value
$969K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/22/2024 | P · Purchase | +47.50K | $20.40 | $969K | 3.8% | 1.25M | 1.30M |
| Total | +47.50K | $969K | ||||||
Derivative Transactions0
No derivative transactions reported